mRNA Vaccines and Therapeutics: The Future of Disease Prevention and Treatment
Messenger RNA (mRNA) vaccines and therapeutics have emerged as groundbreaking innovations in modern medicine, fundamentally changing how we prevent and treat diseases. Unlike traditional vaccines that use weakened or inactivated pathogens, mRNA vaccines work by instructing cells to produce a harmless piece of a pathogen—typically a protein—that triggers an immune response. This technology enables faster development, greater precision, and easier adaptation to new threats, such as emerging infectious diseases or evolving virus variants.
mRNA Vaccines and Therapeutics Market Size was estimated at 6.06 (USD Billion) in 2023. The mRNA Vaccines and Therapeutics Market Industry is expected to grow from 7.23 (USD Billion) in 2024 to 50.0 (USD Billion) by 2035. The mRNA Vaccines and Therapeutics Market CAGR (growth rate) is expected to be around 19.22% during the forecast period (2025 - 2035).
The global spotlight on mRNA technology intensified during the COVID-19 pandemic with the rapid development and approval of…
